This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...
*During data validation and verification for the manuscript, one patient that was originally reported as having a response in the 2021 AACR Annual Meeting presentation of this cohort was found instead ...
Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...
ASCO would like to thank its cosponsors for their support and its committees for their volunteer efforts.
The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer ...
Robin T. Zon, Erin B. Kennedy, Kerin Adelson, Sibel Blau, Natalie Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra Patt, Todd A ...
American Society of Clinical Oncology, Inc. (“ASCO”) permits text links to any of the pages or content on ASCO’s family of websites, in accordance with the terms and conditions set forth in this ...
The American Society of Clinical Oncology (ASCO) is offering free One-Day Quality Training Program Workshops throughout the United States! This is an oncology-focused introduction to quality ...
The 2025 ASCO Annual Meeting begins in just nine days, and we look forward to seeing you in Chicago. As you plan your schedule, consider joining the Association for Clinical Oncology’s advocacy events ...
On June 15 the Supreme Court released a unanimous decision in American Hospital Association et al. v. Becerra, Secretary of Health and Human Services, et al. in favor of the American Hospital ...
On March 14, 2025, Congress passed a continuing resolution (CR) funding the federal government through September 30. The bill also extends telehealth flexibilities in Medicare for the duration of the ...
The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On May 21, 2021, the Food and Drug Administration granted accelerated approval to amivantamab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback